CORAL LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of CORAL LABORATORIES have increased by 3.32% YoY .
The Earnings Per Share (EPS) of CORAL LABORATORIES has decreased by -28.75 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
CORAL LABORATORIES Last 5 Annual Financial Results
[BOM: 524506]
| Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹78 Cr | ₹76 Cr | ₹97 Cr | ₹71 Cr | ₹91 Cr |
| Expenses | ₹74 Cr | ₹67 Cr | ₹81 Cr | ₹65 Cr | ₹79 Cr |
| Operating Profit (Excl OI) | ₹3.81 Cr | ₹8.21 Cr | ₹16 Cr | ₹5.42 Cr | ₹12 Cr |
| Other Income | ₹6.90 Cr | ₹4.81 Cr | ₹3.77 Cr | ₹5.89 Cr | ₹5.16 Cr |
| Interest | ₹0.34 Cr | ₹0.14 Cr | ₹0.04 Cr | ₹0.19 Cr | ₹0.17 Cr |
| Depreciation | ₹2.18 Cr | ₹1.99 Cr | ₹1.98 Cr | ₹2.01 Cr | ₹1.90 Cr |
| Profit Before Tax | ₹8.23 Cr | ₹12 Cr | ₹18 Cr | ₹9.12 Cr | ₹16 Cr |
| Profit After Tax | ₹6.45 Cr | ₹9.05 Cr | ₹14 Cr | ₹7.13 Cr | ₹10 Cr |
| Consolidated Net Profit | ₹6.45 Cr | ₹9.05 Cr | ₹14 Cr | ₹7.13 Cr | ₹10 Cr |
| Earnings Per Share (Rs) | ₹18.04 | ₹25.32 | ₹37.94 | ₹19.96 | ₹28.60 |
| PAT Margin (%) | 8.25 | 11.96 | 14.04 | 10.10 | 11.22 |
| ROE(%) | 4.15 | 6.18 | 10.74 | 6.22 | 8.88 |
| ROCE(%) | 5.41 | 7.87 | 13.35 | 7.86 | 13.44 |
| Total Debt/Equity(x) | 0.00 | 0.04 | 0.05 | 0.05 | 0.01 |
Key Financials |
||
| Market Cap | : | ₹ 133.4 Cr |
| Revenue (TTM) | : | ₹ 66.2 Cr |
| Net Profit(TTM) | : | ₹ 9.1 Cr |
| EPS (TTM) | : | ₹ 25.3 |
| P/E (TTM) | : | 14.6 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| CORAL LABORATORIES | 0.7% | 3.2% | 67% |
| SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
| CIPLA | 2.5% | 0.4% | 71.7% |
| DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
| ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
| DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
| MANKIND PHARMA | NA | NA | NA |
| TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
| LUPIN | 2.8% | 0% | 147.8% |
CORAL LABORATORIES Revenues
[BOM: 524506]
| Y-o-Y | 3.32 % |
| 5 Yr CAGR | -3.77 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹78 Cr | 3.32 | |
| Mar2022 | ₹76 Cr | -21.70 | |
| Mar2021 | ₹97 Cr | 36.82 | |
| Mar2020 | ₹71 Cr | -22.51 | |
| Mar2019 | ₹91 Cr | - | |
CORAL LABORATORIES Operating Profit
[BOM: 524506]
| Y-o-Y | -53.59 % |
| 5 Yr CAGR | -25.57 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹3.81 Cr | -53.59 | |
| Mar2022 | ₹8.21 Cr | -48.17 | |
| Mar2021 | ₹16 Cr | 192.26 | |
| Mar2020 | ₹5.42 Cr | -56.34 | |
| Mar2019 | ₹12 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -55.06 % |
| 5 Yr CAGR | -22.66 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 4.88% | -55.06 | |
| Mar2022 | 10.86% | -33.82 | |
| Mar2021 | 16.41% | 113.67 | |
| Mar2020 | 7.68% | -43.70 | |
| Mar2019 | 13.64% | - | |
CORAL LABORATORIES Profit After Tax
[BOM: 524506]
| Y-o-Y | -28.75 % |
| 5 Yr CAGR | -10.88 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹6.45 Cr | -28.75 | |
| Mar2022 | ₹9.05 Cr | -33.26 | |
| Mar2021 | ₹14 Cr | 90.11 | |
| Mar2020 | ₹7.13 Cr | -30.21 | |
| Mar2019 | ₹10 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -31.02 % |
| 5 Yr CAGR | -7.40 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 8.25 % | -31.02 | |
| Mar2022 | 11.96 % | -14.81 | |
| Mar2021 | 14.04 % | 39.01 | |
| Mar2020 | 10.1 % | -9.98 | |
| Mar2019 | 11.22 % | - | |
CORAL LABORATORIES Earnings Per Share (EPS)
[BOM: 524506]
| Y-o-Y | -28.75 % |
| 5 Yr CAGR | -10.88 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹18 | -28.75 | |
| Mar2022 | ₹25 | -33.26 | |
| Mar2021 | ₹38 | 90.08 | |
| Mar2020 | ₹20 | -30.21 | |
| Mar2019 | ₹29 | - | |
CORAL LABORATORIES Return on Capital Employed (ROCE)
[BOM: 524506]
| Y-o-Y | -31.26 % |
| 5 Yr CAGR | -20.35 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 5.41% | -31.26 | |
| Mar2022 | 7.87% | -41.05 | |
| Mar2021 | 13.35% | 69.85 | |
| Mar2020 | 7.86% | -41.52 | |
| Mar2019 | 13.44% | - | |
CORAL LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹370.5 |
| Current MarketCap | : | ₹ 133.4 Cr |
| Updated EOD on | : | Apr 23,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORAL LABORATORIES | 0.7% |
3.2% |
67% |
| SENSEX | 0.5% |
1.4% |
23.5% |
CORAL LABORATORIES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about CORAL LABORATORIES Financials
How the annual revenues of CORAL LABORATORIES have changed ?
The Revenues of CORAL LABORATORIES have increased by 3.32% YoY .
How the Earnings per Share (EPS) of CORAL LABORATORIES have changed?
The Earnings Per Share (EPS) of CORAL LABORATORIES has decreased by -28.75 % YoY .
Check out Intrinsic Value of Peers of CORAL LABORATORIES
Compare Stock Analytics of Peers of CORAL LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
